Pharmaceutical Company Sued Over Drug Causing Birth Defects
GlaxoSmithKline LLC, the makers of Zofran, have been sued in federal court by a couple claiming that taking Zofran during pregnancy caused birth defects in their son.
Sicily Lafleur and Justin Lee Thibodeaux, both individually and as parents and natural tutors of their son, Kaden L. Lafleur, a minor, filed suit against GlaxoSmithKline LLC on February 23 in the U.S. District Court for the the Western District of Louisiana, Lafayette Division. The claims cited are negligence, misrepresentation, fraud, and breach of implied and express warranty.
According to the suit, Lafleur was prescribed Zofran in the beginning of her first trimester to alleviate morning sickness by her health care provider in Lafayette. The product of that pregnancy, Kaden L. Lafleur, was born on November 7, 2012, with congenital heart defects. The plaintiffs allege that these defects are a direct and proximate result of Kaden’s prenatal exposure to Zofran. As a result of these defects, Kaden purportedly required surgery immediately after birth as well as extensive follow-up treatments.